A UK study has found that people using weight loss injections like Wegovy and Mounjaro face an 11 times higher risk of experiencing dangerous surgery complications. The research highlights a potential link between these medications and a condition known as regurgitation, where stomach contents rise into the throat or mouth. This can lead to serious health risks, as liquid or food from the stomach may enter the airway, causing choking or infection.
The findings, based on a detailed analysis of patient records, suggest that the risk is particularly elevated during surgical procedures. Researchers warn that healthcare professionals should be aware of this potential complication when considering treatment options for patients. While the study does not establish a direct cause-and-effect relationship, it raises important concerns about the safety profile of these weight loss drugs.
More research is needed to fully understand the implications of these findings. Patients using such medications are advised to discuss any concerns with their healthcare providers before undergoing surgery. The study adds to growing discussions about the long-term effects of weight loss treatments and their impact on medical procedures.
